In our previous study, in an endoglin non-expressing TS/A adenocarcinoma tumor model, the anti-tumor effect of pU6-antiCD105 plasmid was evaluated with the aim of demonstrating the anti-vascular effect of endoglin silencing [18]. The gene discussed is ENG; the disease is neoplasm.